Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP524364.RADzYtXZz_zyPQll81G_du1SP_rFYep1n5RWPvS3THGlA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP524364.RADzYtXZz_zyPQll81G_du1SP_rFYep1n5RWPvS3THGlA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP524364.RADzYtXZz_zyPQll81G_du1SP_rFYep1n5RWPvS3THGlA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP524364.RADzYtXZz_zyPQll81G_du1SP_rFYep1n5RWPvS3THGlA130_provenance.
- befree-20150227 importedOn "2015-02-27" NP524364.RADzYtXZz_zyPQll81G_du1SP_rFYep1n5RWPvS3THGlA130_provenance.
- NP524364.RADzYtXZz_zyPQll81G_du1SP_rFYep1n5RWPvS3THGlA130_assertion wasGeneratedBy ECO_0000203 NP524364.RADzYtXZz_zyPQll81G_du1SP_rFYep1n5RWPvS3THGlA130_provenance.
- NP524364.RADzYtXZz_zyPQll81G_du1SP_rFYep1n5RWPvS3THGlA130_assertion wasDerivedFrom befree-20150227 NP524364.RADzYtXZz_zyPQll81G_du1SP_rFYep1n5RWPvS3THGlA130_provenance.
- NP524364.RADzYtXZz_zyPQll81G_du1SP_rFYep1n5RWPvS3THGlA130_assertion SIO_000772 21039418 NP524364.RADzYtXZz_zyPQll81G_du1SP_rFYep1n5RWPvS3THGlA130_provenance.
- NP524364.RADzYtXZz_zyPQll81G_du1SP_rFYep1n5RWPvS3THGlA130_assertion evidence source_evidence_literature NP524364.RADzYtXZz_zyPQll81G_du1SP_rFYep1n5RWPvS3THGlA130_provenance.
- NP524364.RADzYtXZz_zyPQll81G_du1SP_rFYep1n5RWPvS3THGlA130_assertion description "[Clinical results of osanetant and talnetant (selective-NK₃ antagonists) indicate that blocking the NK₃ receptor could be beneficial for the treatment of schizophrenia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP524364.RADzYtXZz_zyPQll81G_du1SP_rFYep1n5RWPvS3THGlA130_provenance.